...
首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients?: a comparative study of 1398 high-risk patients.
【24h】

Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients?: a comparative study of 1398 high-risk patients.

机译:体外循环冠状动脉搭桥术(OPCAB)可以改善高危患者的预后吗?:一项对1398名高危患者的比较研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Although there has been some evidence supporting the theoretical and practical advantages of off-pump coronary artery bypass (OPCAB) over the conventional coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB), it has not yet been determined which group of patients would benefit most from it. It has been advocated recently that high-risk patients could benefit most from avoidance of CPB. The aim of this retrospective study is to assess the efficacy of the OPCAB technique in multi-vessel myocardial revascularization in a large series of high-risk patients. METHODS: The records of 1398 consecutive high-risk patients who underwent primary isolated CABG at Harefield Hospital between August 1996 and December 2001 were reviewed retrospectively. Patients were considered as high-risk and included in the study if they had a preoperative EuroSCORE of >/=5. Two hundred and eighty-six patients were operated on using the OPCAB technique while 1112 patients were operated on using the conventional CABG technique with CPB. The OPCAB patients were significantly older than the CPB patients (68.1+/-8.3 vs. 63.7+/-9.9 years, respectively, P<0.001). The OPCAB group included significantly more patients with poor left ventricular (LV) function (ejection fraction (EF)
机译:目的:尽管有一些证据支持非体外循环冠状动脉搭桥术(OPCAB)优于传统的体外循环冠状动脉搭桥术(CPB)的冠状动脉搭桥术(CABG),但尚未确定哪一组患者将从中受益最大。最近有人提倡,避免CPB可使高危患者受益最多。这项回顾性研究的目的是评估OPCAB技术在一系列高危患者中在多支血管心肌血运重建中的功效。方法:回顾性分析1996年8月至2001年12月在Harefield医院接受原发性CABG的1398例连续高危患者的病历。如果患者术前EuroSCORE> / = 5,则认为该患者为高危患者。 286例患者使用OPCAB技术进行手术,而1112例患者使用常规CABG技术和CPB进行手术。 OPCAB患者的年龄明显大于CPB患者(分别为68.1 +/- 8.3岁和63.7 +/- 9.9岁,P <0.001)。 OPCAB组包括明显更多的左心室(LV)功能差(射血分数(EF)≤30%)(P <0.001)的患者和更多的肾病患者(P <0.001)。结果:两组之间的移植物数量没有显着差异。 CPB患者每人接受2.8 +/- 1.2移植物,而OPCAB患者每人接受2.8 +/- 0.5移植物(P = 1)。 21名(7.3%)OPCAB患者有一种或多种主要并发症,而158名(14.2%)CPB患者(P = 0.008)出现了严重并发症。 38名(3.4%)CPB患者发生围手术期心肌梗塞(MI),而只有2名(0.7%)OPCAB患者发生围手术期心肌梗塞(P = 0.024)。 OPCAB患者的强化治疗单元(ITU)停留时间为29.3 +/- 15.4 h,而CPB患者的停留时间为63.6 +/- 167.1 h(P <0.001)。术后30天内,OPCAB患者死亡10例(3.5%),而CPB患者死亡78例(7%)(P = 0.041)。结论:这项回顾性研究表明,在高危患者中使用OPCAB技术进行多支血管心肌血运重建可显着降低围手术期MI和其他主要并发症的发生率,ITU住院率和死亡率。即使OPCAB组包括明显更高比例的LV功能差(EF≤30%)和肾病的老年患者,OPCAB的有益作用也是显而易见的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号